Gestational trophoblastic malignancy.
Gestational trophoblastic malignancy, although rare, offers the clinician the opportunity of being able to cure a malignant disease with cytotoxic chemotherapy. Such an opportunity is fulfilled only when the progress of the post-molar patients is monitored and chemotherapy instituted as soon as the malignant transformation of the mole is documented. The management and treatment of nine cases is presented and discussed.
D000328:Adult; D002822:Choriocarcinoma / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006801:Humans; D007044:Hysterectomy; D002955:Leucovorin / Q000627:therapeutic use*; D015122:Mercaptopurine / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use*; D011247:Pregnancy; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000601:surgery
D015122:Mercaptopurine; D002955:Leucovorin; D008727:Methotrexate